Pharma Journalist -

Aries Pharmaceuticals, Inc. (Aries) today announced the launch and commercial availability of its first product, Eleview™, a novel, ready to use, submucosal injectable composition for…
Read More...

bluebird bio, Inc. announced that it has entered into a worldwide license agreement around its proprietary lentiviral vector platform with GlaxoSmithKline Intellectual Property…
Read More...

Pillsy, the first smart pill bottle and mobile app that helps users take control of their health and the health of others, has launched and is now available for purchase online. The…
Read More...

bluebird bio announced that it has entered into a worldwide license agreement around its proprietary lentiviral vector platform with Novartis Pharma AG. “bluebird bio is a pioneer in…
Read More...

BioAxone BioSciences, Inc., a clinical-stage biotechnology company focused on developing innovative drugs to restore neurological function, announced that it has entered a contract with…
Read More...

Nanotherapeutics Bohumil s.r.o. (a wholly owned subsidiary of Nanotherapeutics, Inc.) and Cyrus Poonawalla Group announced today the final transfer of Nanotherapeutics Bohumil s.r.o.’s…
Read More...

Atlantic Healthcare plc (“Atlantic Healthcare”), an emerging trans-Atlantic pharmaceutical company with a core focus on gastrointestinal (GI) disorders, announces that it has initiated…
Read More...

Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) announced today that the Company will withdraw its European Marketing Authorization Application (MAA) for vosaroxin as a treatment for…
Read More...

Neurotrope, Inc. announced positive top-line results from its Phase 2 study (-202 Study) of Bryostatin-1 in patients with moderate to severe Alzheimer's disease (AD), a population not…
Read More...

GSK announced $139 million of new investment in its biopharmaceutical manufacturing site in Rockville, MD to support growing demand for BENLYSTA® (belimumab) for adult patients with…
Read More...